Anna Westerlund, Halah Khalifa, Ranna Yousif, Gustavo Silva Araujo, Evelina Lundqvist, Erica Larsson, Rakel Thrastardottir, Rebecka Akhlaghi, Victoria Granciuc, Charlotta Svanberg, Maria André, Anna Lehrkinder, Farhan Bazargani, Christina Goriel Radsjö, Caspar Carlfjord, Anke Krämer, Niels Ganzer, Isabell Hansson, Erik Frilund, Eva Josefsson, Rune Lindsten, Anders Magnusson, Brygida Grunwald, Firas Hittini, Nurije Kryeziu, Henning Looström, Mikael Sonesson, Reem Al-Taha, Hanna Surac, Seifi Esmaili, Haris Isic, Anna Tegnell, Samuel Andersson, Mai Lin Lövgren, Jenny Kallunki, Anna E Lorenzo, Elena Arezzo, Agata Jasna, Tumkur Sitaram Raviprakash, Ewa Strömqvist-Engbo, Amanda Burstedt, William Rosenbaum, Oscar öhman, Wolfgang Lohr, Ann-Charlotte Rönn, Tomas Axelsson, Lena Mårell, Lennart österman, Edward J Hollox, Ulrika Westerlind, Karina Persson, Henrik Clausen, Per Liv, Patrik Ryden, Johan Henriksson, Laura Carroll, Nongfei Sheng, Pär Larsson, Nicklas Strömberg
{"title":"Personalized oral care (Precaries): an intervention study customized according to genetic cause and risk","authors":"Anna Westerlund, Halah Khalifa, Ranna Yousif, Gustavo Silva Araujo, Evelina Lundqvist, Erica Larsson, Rakel Thrastardottir, Rebecka Akhlaghi, Victoria Granciuc, Charlotta Svanberg, Maria André, Anna Lehrkinder, Farhan Bazargani, Christina Goriel Radsjö, Caspar Carlfjord, Anke Krämer, Niels Ganzer, Isabell Hansson, Erik Frilund, Eva Josefsson, Rune Lindsten, Anders Magnusson, Brygida Grunwald, Firas Hittini, Nurije Kryeziu, Henning Looström, Mikael Sonesson, Reem Al-Taha, Hanna Surac, Seifi Esmaili, Haris Isic, Anna Tegnell, Samuel Andersson, Mai Lin Lövgren, Jenny Kallunki, Anna E Lorenzo, Elena Arezzo, Agata Jasna, Tumkur Sitaram Raviprakash, Ewa Strömqvist-Engbo, Amanda Burstedt, William Rosenbaum, Oscar öhman, Wolfgang Lohr, Ann-Charlotte Rönn, Tomas Axelsson, Lena Mårell, Lennart österman, Edward J Hollox, Ulrika Westerlind, Karina Persson, Henrik Clausen, Per Liv, Patrik Ryden, Johan Henriksson, Laura Carroll, Nongfei Sheng, Pär Larsson, Nicklas Strömberg","doi":"10.1101/2024.01.23.24300787","DOIUrl":null,"url":null,"abstract":"ABSTRACT\nIntroduction Dental caries is a disease that affects billions of people, and involves high and low genetic susceptibility phenotypes and different causal subtypes. The randomized clinical trial Precaries-RCT will evaluate caries prevention in adolescents, customized according to genetic cause and risk. Here we describe the Precaries-RCT and two nested Precaries studies for cost-efficient oral healthcare and personalized dentistry.\nMethods and analysis Here we present a basic and adaptive protocol for the Precaries-RCT multicentre caries intervention study, customized according to genetic cause and risk. It includes prescreening for high versus low genetic caries susceptibility, through self-performed sampling by mail of up to 2000 adolescents aimed for orthodontic treatment at community clinics, of which 520 are enrolled in the RCT. The participants are allocated into two groups — a high and a low genetic caries susceptibility group — that each is assigned to intensive or standard prevention. The primary outcome is % reduction in caries increment, relative to prevention and genotype, with caries outcomes measured using tactile and visual methods, bitewing radiographs, clinical photos, and quantitative laser fluorescence. The adaptive design allows for determination of incidence and progression rates and for inclusion of additional human and microbiota biomarkers and study subjects. Biological samples (e.g. swab DNA, whole and parotid saliva, and microbiota) and questionnaire data are collected. Here we also outline the nested Precaries-adolescent sample for mining of predictor and therapeutic target genes and Precaries-birth cohort samples for implementation of our findings in childhood.\nEthics and dissemination Ethical approval was obtained from the Swedish national board research ethics committee (Dnr 2020-02533). Informed consent will be obtained from each participant. The findings will be disseminated to the public through conference presentations and publication in peer-reviewed scientific journals.\nTrial registration number www.clinicaltrials.gov, NCT05600517","PeriodicalId":501363,"journal":{"name":"medRxiv - Dentistry and Oral Medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Dentistry and Oral Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.01.23.24300787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
ABSTRACT
Introduction Dental caries is a disease that affects billions of people, and involves high and low genetic susceptibility phenotypes and different causal subtypes. The randomized clinical trial Precaries-RCT will evaluate caries prevention in adolescents, customized according to genetic cause and risk. Here we describe the Precaries-RCT and two nested Precaries studies for cost-efficient oral healthcare and personalized dentistry.
Methods and analysis Here we present a basic and adaptive protocol for the Precaries-RCT multicentre caries intervention study, customized according to genetic cause and risk. It includes prescreening for high versus low genetic caries susceptibility, through self-performed sampling by mail of up to 2000 adolescents aimed for orthodontic treatment at community clinics, of which 520 are enrolled in the RCT. The participants are allocated into two groups — a high and a low genetic caries susceptibility group — that each is assigned to intensive or standard prevention. The primary outcome is % reduction in caries increment, relative to prevention and genotype, with caries outcomes measured using tactile and visual methods, bitewing radiographs, clinical photos, and quantitative laser fluorescence. The adaptive design allows for determination of incidence and progression rates and for inclusion of additional human and microbiota biomarkers and study subjects. Biological samples (e.g. swab DNA, whole and parotid saliva, and microbiota) and questionnaire data are collected. Here we also outline the nested Precaries-adolescent sample for mining of predictor and therapeutic target genes and Precaries-birth cohort samples for implementation of our findings in childhood.
Ethics and dissemination Ethical approval was obtained from the Swedish national board research ethics committee (Dnr 2020-02533). Informed consent will be obtained from each participant. The findings will be disseminated to the public through conference presentations and publication in peer-reviewed scientific journals.
Trial registration number www.clinicaltrials.gov, NCT05600517